COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY